Rohto and Mitsui lead acquisition of Eu Yan Sang for $695M

  • 📰 SBRMagazine
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 51%

España Noticias Noticias

España Últimas Noticias,España Titulares

pstrongThe Japanese companies acquired an 86% stake in the company./strong/p pA consortium led by Japanese companies Rohto Pharmaceutical and Mitsui & Co. has acquired Singapore-based traditional Chinese medicine company a href="https://sbr.com.

The Japanese companies acquired an 86% stake in the company.RCH is an investment holding company owned by Tower Capital Asia subsidiary, Tower Capital TCM Holdings, and Temasek Holdings unit Blanca Investments.

“In 2016, we chose to partner with Tower Capital Asia due to their understanding of the Eu Yan Sang heritage and commitment to driving excellence. Tower Capital Asia, together with Temasek, was instrumental in elevating the EYSI brand, institutionalising operations, and establishing the foundation for our next chapter as a natural health and wellness brand," said Richard Eu, chairman of EYSI....there are many ways you can work with us to advertise your company and connect to your customers.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

 /  🏆 13. in ES
 

Gracias por tu comentario. Tu comentario será publicado después de ser revisado.

España Últimas Noticias, España Titulares